BBOT

Conviction 30HealthcareScan · Fri, Jun 26, 2026

BBOT$7.45-3.12%

ResistanceSupportVol 14

Vol MA14 997.3K

Mar 27Apr 15May 4May 20Jun 9Jun 26

BridgeBio Oncology Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.bridgebio.com ↗

Price7.45

Change-3.12%

Gap+1.56%

Rel volume13.30×

Avg volume755.36K

Avg $ vol5.73M

SMA 207.79

SMA 508.27

SMA 20010.49

Price vs 50-9.94%

Price vs 200-28.96%

MA stackbearish

50/200 cross—

Supertrenddown · 8.90

RSI (14)42

MACD hist0.01

MACD crossbull · 1d

Stoch %K / %D39 / 42

ADX (14)15

+DI / −DI18 / 19

RSI divergence—

MACD divergence—

ATR %+7.02%

ADR %6.45%

52w high13.73

52w low7.12

From 52w high-45.74%

Above 52w low+4.63%

New 52w highNo

SqueezeOff

Bollinger width22.08%

%B0.30

Donchian pos20.00%

Donchian high9.25

Donchian low7.00

AVWAP (52w high)9.42

vs AVWAP high-20.91%

AVWAP (52w low)7.63

vs AVWAP low-2.38%

OBV trendDown

Chaikin MF (20)-0.48

Today vs 20d13.30×

Avg vol (14d)997.3K

Avg vol (20d)755.36K

Avg $ vol (20d)5.73M

Market cap—

RS 3m (vs SPY)-28.66%

RS 6m (vs SPY)-44.09%

RS line new highNo

Trend template—

Technical rank13.3

1 week-1.46%

1 month-12.66%

3 months-19.28%

6 months-37.55%

1 year—

YTD-39.38%

P/E-4.58

P/B1.65

P/S—

P/FCF-5.37

EPS-4.30

Div yield—

ROE-36.01%

ROA-32.10%

Debt/Eq—

Current6.16

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-80.47%

Price target23.00

Target upside199.87%

Analyst ratingBuy

Institutional69.42%

Ent. value561.76M

Revenue—

Net income-42.11M

Gross profit—

Free cash flow-114.5M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out80.11M

Employees106

ListedTue, Aug 12, 2025

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction30 / 100

Pattern quality—

Tech rank13.3 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance9.26

Support7.15

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in BBOT

All disclosures →

No recent disclosed trades by Congress in BBOT. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in BBOT · 9 buys · 1 sell

Insider	Side	Shares	Value	Traded	Filed
Bauer Jake Director · Stock Option (Right to Buy) · 2026-06-16	Grant	31.68K	—	2026-06-16	2026-06-18
Kumar Neil Director · Stock Option (Right to Buy) · 2026-06-16	Grant	31.68K	—	2026-06-16	2026-06-18
Chen Bihua Director · Stock Option (Right to Buy) · 2026-06-16	Grant	31.68K	—	2026-06-16	2026-06-18
Kelleher Raymond J. Director · Stock Option (Right to Buy) · 2026-06-16	Grant	31.68K	—	2026-06-16	2026-06-18
Lebowitz Peter F Director · Stock Option (Right to Buy) · 2026-06-16	Grant	7.29K	—	2026-06-16	2026-06-18
MCCORMICK FRANK Director · Stock Option (Right to Buy) · 2026-06-16	Grant	31.68K	—	2026-06-16	2026-06-18
Tipirneni Praveen P. Director · Stock Option (Right to Buy) · 2026-06-16	Grant	31.68K	—	2026-06-16	2026-06-18
Elmelech Idan COO & Principal Financial Ofcr · Stock Option (Right to Buy) · 2026-05-10	Grant	758.22K	$0	2026-05-10	2026-05-12
Beltran Pedro President and CEO · Stock Option (Right to Buy) · 2026-05-10	Grant	1.1M	$0	2026-05-10	2026-05-12
Beltran Pedro President and CEO · Common Stock · 2026-04-01	Tax	1.05K	$9K	2026-04-01	2026-05-05

SEC filings

EDGAR filings in BBOT · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.